




Searching News Database: BioCryst
HSMN NewsFeed - 3 Apr 2017
BioCryst Announces Mundipharma Receives Approval for Mundesine(R) in Japan
BioCryst Announces Mundipharma Receives Approval for Mundesine(R) in Japan
HSMN NewsFeed - 13 Jun 2014
Theravance, Inc. Appoints George B. Abercrombie as Senior Vice President, Corporate Partnerships, Commercial
Theravance, Inc. Appoints George B. Abercrombie as Senior Vice President, Corporate Partnerships, Commercial
HSMN NewsFeed - 30 Nov 2012
BioCryst Pharmaceuticals and Presidio Pharmaceuticals Mutually Terminate Merger Transaction
BioCryst Pharmaceuticals and Presidio Pharmaceuticals Mutually Terminate Merger Transaction
HSMN NewsFeed - 25 May 2011
BioCryst Pharmaceuticals Announces Appointment of Thomas Staab as Its Next Chief Financial Officer
BioCryst Pharmaceuticals Announces Appointment of Thomas Staab as Its Next Chief Financial Officer
HSMN NewsFeed - 13 Jan 2010
BioCryst's Partner Shionogi Receives Marketing & Manufacturing Approval For Peramivir in Japan
BioCryst's Partner Shionogi Receives Marketing & Manufacturing Approval For Peramivir in Japan
HSMN NewsFeed - 18 Jun 2008
William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
HSMN NewsFeed - 8 Aug 2007
BioCryst Appoints Elliott T. Berger, Ph.D., Senior Vice President of Regulatory Affairs
BioCryst Appoints Elliott T. Berger, Ph.D., Senior Vice President of Regulatory Affairs
HSMN NewsFeed - 26 Jul 2007
BioCryst Announces Realignment and Strengthening of the Company's Executive Management Team
BioCryst Announces Realignment and Strengthening of the Company's Executive Management Team
HSMN NewsFeed - 25 Jan 2007
BioCryst Initiates Phase II Influenza Clinical Trial to Evaluate Peramivir
BioCryst Initiates Phase II Influenza Clinical Trial to Evaluate Peramivir
Additional items found! 15

Members Archive contains
15 additional stories matching:
BioCryst
(Password required)
BioCryst
(Password required)